---
document_datetime: 2025-11-20 12:08:01
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/atectura-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: atectura-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.46807
conversion_datetime: 2025-12-28 04:10:28.675275
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Atectura Breezhaler

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 20/11/2025                          |                                             | Labelling and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000312770                      | Update of the labelling and package leaflet, section 'Instruction for Use', to delete the QR code and related website information.                                                                                                                                                                                                                                                                                                                                                |            |     | PL                               |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------|
| Variation type IA / EMA/VR/0000303597 | This was an application for a group of variations. A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted B.II.e.5 Change in pack size of the finished product - B.II.e.5.b Deletion of pack size(s) - | 29/10/2025 |     | SmPC, Annex II, Labelling and PL |
| Variation type IA / EMA/VR/0000244278 | A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted A. ADMINISTRATIVE CHANGES - A.7                                                                                                                 | 31/07/2025 | N/A |                                  |

<div style=\"page-break-after: always\"></div>

| substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted B.III.1.b European Pharmacopoeial TSE Certificate of suitability for an active substance/starting material/reagent/ intermediate/or excipient - B.III.1.b.4 Deletion of certificates (in case multiple   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| certificates exist per material) - Accepted   |
|-----------------------------------------------|
| B.III.1.b European Pharmacopoeial TSE         |
| Certificate of suitability for an active      |
| substance/starting material/reagent/          |
| intermediate/or excipient - B.III.1.b.2 New   |
| certificate for a starting material/reagent/  |
| intermediate/or excipient from a new or an    |
| already approved manufacturer - Accepted      |
| B.III.1.b European Pharmacopoeial TSE         |
| Certificate of suitability for an active      |
| substance/starting material/reagent/          |
| intermediate/or excipient - B.III.1.b.2 New   |
| certificate for a starting material/reagent/  |
| intermediate/or excipient from a new or an    |
| already approved manufacturer - Accepted      |